By Professor Dedee Frances Murrell

Journal articles

Lebwohl M; Rivera-Oyola R; Murrell DF, 2020, 'Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”', Journal of the American Academy of Dermatology, 82, pp. e215, http://dx.doi.org/10.1016/j.jaad.2020.03.103

Murrell DF; Murase JE, 2020, 'The Potential Protective Effect of Estrogen: Why is COVID-19 mortality lower in females than males', International Journal of Women's Dermatology, 6, pp. 152 - 153, http://dx.doi.org/10.1016/j.ijwd.2020.04.011

Murase JE; Murrell DF, 2020, 'The response of the Women's Dermatologic Society and the International Journal of Women's Dermatology to the COVID-19 pandemic', International Journal of Women's Dermatology, 6, pp. 129 - 130, http://dx.doi.org/10.1016/j.ijwd.2020.04.008

Shakshouk H; Daneshpazhooh M; Murrell DF; Lehman JS, 2020, 'Treatment considerations for patients with pemphigus during the COVID-19 pandemic', Journal of the American Academy of Dermatology, 82, pp. e235 - e236, http://dx.doi.org/10.1016/j.jaad.2020.04.005

Gibson M; Murrell DF, 2020, 'Drug-related adverse effects of vismodegib and sonidegib for locally advanced or metastatic basal cell carcinoma', Australasian Journal of Dermatology, 61, pp. 176 - 177, http://dx.doi.org/10.1111/ajd.13205

Lebwohl M; Rivera-Oyola R; Murrell DF, 2020, 'Should biologics for psoriasis be interrupted in the era of COVID-19?', Journal of the American Academy of Dermatology, 82, pp. 1217 - 1218, http://dx.doi.org/10.1016/j.jaad.2020.03.031

Murrell DF; Peña S; Joly P; Marinovic B; Hashimoto T; Diaz LA; Sinha AA; Payne AS; Daneshpazhooh M; Eming R; Jonkman MF; Mimouni D; Borradori L; Kim SC; Yamagami J; Lehman JS; Saleh MA; Culton DA; Czernik A; Zone JJ; Fivenson D; Ujiie H; Wozniak K; Akman-Karakaş A; Bernard P; Korman NJ; Caux F; Drenovska K; Prost-Squarcioni C; Vassileva S; Feldman RJ; Cardones AR; Bauer J; Ioannides D; Jedlickova H; Palisson F; Patsatsi A; Uzun S; Yayli S; Zillikens D; Amagai M; Hertl M; Schmidt E; Aoki V; Grando SA; Shimizu H; Baum S; Cianchini G; Feliciani C; Iranzo P; Mascaró JM; Kowalewski C; Hall R; Groves R; Harman KE; Marinkovich MP; Maverakis E; Werth VP, 2020, 'Diagnosis and management of pemphigus: Recommendations of an international panel of experts', Journal of the American Academy of Dermatology, 82, pp. 575 - 585.e1, http://dx.doi.org/10.1016/j.jaad.2018.02.021

Bilgic A; Murrell DF, 2020, 'Novel diagnostic method to differentiate antilaminin-332 pemphigoid from other forms of pemphigoid', British Journal of Dermatology, 182, pp. 270 - 271, http://dx.doi.org/10.1111/bjd.18372

Bruckner AL; Losow M; Wisk J; Patel N; Reha A; Lagast H; Gault J; Gershkowitz J; Kopelan B; Hund M; Murrell DF, 2020, 'The challenges of living with and managing epidermolysis bullosa: Insights from patients and caregivers', Orphanet Journal of Rare Diseases, 15, http://dx.doi.org/10.1186/s13023-019-1279-y

Silverberg JI; Pinter A; Pulka G; Poulin Y; Bouaziz JD; Wollenberg A; Murrell DF; Alexis A; Lindsey L; Ahmad F; Piketty C; Clucas A, 2020, 'Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus', Journal of Allergy and Clinical Immunology, 145, pp. 173 - 182, http://dx.doi.org/10.1016/j.jaci.2019.08.013

Yang A; Xuan R; Melbourne W; Tran K; Murrell DF, 2020, 'Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus', Journal of the European Academy of Dermatology and Venereology, 34, pp. 153 - 160, http://dx.doi.org/10.1111/jdv.15770

Verheyden M; Murrell D; Bilgic A, 2020, '12871 A systematic review of drug-induced pemphigoid', Journal of the American Academy of Dermatology, 83, pp. AB113 - AB113, http://dx.doi.org/10.1016/j.jaad.2020.06.539

Mahajan R; Bishnoi A; Manjunath S; Kishore K; De D; Murrell DF; Handa S, 2020, '17891 Quality of life score in Indian patients with epidermolysis bullosa and its correlation with clinical severity assessment scores', Journal of the American Academy of Dermatology, 83, pp. AB202 - AB202, http://dx.doi.org/10.1016/j.jaad.2020.06.896

Gorell E; Eng V; Solis D; Choi S; Nazaroff J; Li S; de Souza M; Murrell D; Marinkovich MP; Tang J, 2020, '282 Larger wounds in recessive dystrophic epidermolysis bullosa patients associated with worse quality of life: Results of a global cross-sectional survey', Journal of Investigative Dermatology, 140, pp. S34 - S34, http://dx.doi.org/10.1016/j.jid.2020.03.288

Yang A; Xuan RR; Melbourne W; Hashimoto T; Uzun S; Daneshpazhooh M; Yamagami J; Di Zenzo G; Mascaro JM; Mahmoudi H; Patsatsi A; Drenovska K; Vassileva S; Murrell DF, 2019, 'Inter-rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients', Journal of the European Academy of Dermatology and Venereology, 33, pp. 2327 - 2333, http://dx.doi.org/10.1111/jdv.15817

Blake SC; Murrell DF, 2019, 'Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review', Pediatric Dermatology, 36, pp. 843 - 853, http://dx.doi.org/10.1111/pde.13999

Gibson M; Murrell DF; Daniel BS, 2019, 'Mycobacterium chelonae infection mimicking demodex folliculitis.', Clin Exp Dermatol, http://dx.doi.org/10.1111/ced.14132

Bilgic A; Murrell DF, 2019, 'What is novel in the clinical management of pemphigus', Expert Review of Clinical Pharmacology, 12, pp. 973 - 980, http://dx.doi.org/10.1080/17512433.2019.1670059

Chavez A; Licholai G; Murrell DF, 2019, 'Patients left behind: Rare dermatologic conditions miss the orphan drug development boom', Journal of the American Academy of Dermatology, 81, pp. 1025 - 1026, http://dx.doi.org/10.1016/j.jaad.2019.03.013

Chen JSC; Yang A; Murrell DF, 2019, 'Prevalence and pathogenesis of osteopenia and osteoporosis in epidermolysis bullosa: An evidence-based review', Experimental Dermatology, 28, pp. 1122 - 1130, http://dx.doi.org/10.1111/exd.13771

FREW J; MURRELL DF, 2019, 'Improving clinical applications of quality of life scores in epidermolysis bullosa: defining clinically significant outcomes in the QOLEB questionnaire', Mucosa, 2, pp. 68 - 75, http://dx.doi.org/10.33204/mucosa.598339

BİLGİC A; MURRELL DF, 2019, 'Toxicity of glucocorticosteroids in autoimmune blistering diseases', Mucosa, 2, pp. 59 - 67, http://dx.doi.org/10.33204/mucosa.607952

Blake SC; O'Dea S; Murrell DF, 2019, 'A chlorhexidine conundrum after an epidural delivery: The difficulty of differentiating between chlorhexidine burns and hypersensitivity reactions', International Journal of Women's Dermatology, 5, pp. 269 - 270, http://dx.doi.org/10.1016/j.ijwd.2019.04.023

Murase JE; Murrell DF; Aigen AR, 2019, 'Introduction to the clinical images section', International Journal of Women's Dermatology, 5, pp. 213, http://dx.doi.org/10.1016/j.ijwd.2019.06.001

Daniel BS; Murrell DF, 2019, 'Review of autoimmune blistering diseases: the Pemphigoid diseases', Journal of the European Academy of Dermatology and Venereology, 33, pp. 1685 - 1694, http://dx.doi.org/10.1111/jdv.15679

Xie D; Bilgic-Temel A; Abu Alrub N; Murrell DF, 2019, 'Alopecia in Autoimmune Blistering Diseases: A Systematic Review of Pathogenesis and Clinical Features of Disease', Skin Appendage Disorders, 5, pp. 263 - 275, http://dx.doi.org/10.1159/000496836

Saleh MA; Zaraa I; Doss N; Saleh NA; Murrell DF, 2019, 'Assessment of the quality of life of egyptian and tunisian autoimmune bullous diseases' patients using an arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires', Anais Brasileiros de Dermatologia, 94, pp. 399 - 404, http://dx.doi.org/10.1590/abd1806-4841.20197198

Patsatsi A; Marinovic B; Murrell D, 2019, 'Autoimmune bullous diseases during pregnancy: Solving common and uncommon issues', International Journal of Women's Dermatology, 5, pp. 166 - 170, http://dx.doi.org/10.1016/j.ijwd.2019.01.003

Bilgic-Temel A; Murrell DF; Uzun S, 2019, 'Cutaneous leishmaniasis: A neglected disfiguring disease for women', International Journal of Women's Dermatology, 5, pp. 158 - 165, http://dx.doi.org/10.1016/j.ijwd.2019.01.002

Murase JE; Murrell DF, 2019, 'Introduction to The Art of Prevention series', International Journal of Women's Dermatology, 5, pp. 151, http://dx.doi.org/10.1016/j.ijwd.2019.05.004

Xie D; Bilgic-Temel A; Abu Alrub N; Murrell DF, 2019, 'Pathogenesis and clinical features of alopecia in epidermolysis bullosa: A systematic review', Pediatric Dermatology, 36, pp. 430 - 436, http://dx.doi.org/10.1111/pde.13866

Bilgic A; Murrell DF, 2019, 'Pemphigus vulgaris accompanied with amyotrophic lateral sclerosis: a rare coincidence or pathogenic relationship?', European Journal of Dermatology, 29, pp. 435 - 436, http://dx.doi.org/10.1684/ejd.2019.3577

Bilgic-Temel A; Das S; Murrell DF, 2019, 'Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report', International Journal of Women's Dermatology, 5, pp. 179 - 180, http://dx.doi.org/10.1016/j.ijwd.2019.02.001

Gibson M; Murrell D, 2019, 'Is it psoriasis, a virus, or fungal infection?', Australian Doctor

Bilgic Temel A; Murrell DF, 2019, 'Pharmacological advances in pemphigus', Current Opinion in Pharmacology, 46, pp. 44 - 49, http://dx.doi.org/10.1016/j.coph.2019.01.001

Sekulic A; Migden MR; Basset-Seguin N; Garbe C; Gesierich A; Lao CD; Miller C; Mortier L; Murrell DF; Hamid O; Quevedo JF; Hou J; McKenna E; Dimier N; Williams S; Schadendorf D; Hauschild A, 2019, 'Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)', BMC Cancer, 19, http://dx.doi.org/10.1186/s12885-019-5568-6

Bilgic-Temel A; Irican C; Uzun S; Feng GYH; Murrell DF; Akman-Karakas A, 2019, 'Quality of life in turkish patients with autoimmune blistering diseases: Reliability and validity of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires', Turkish Journal of Dermatology, 13, pp. 83 - 90, http://dx.doi.org/10.4103/tjd.tjd_16_19

Phan K; Goyal S; Murrell DF, 2019, 'Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies', Australasian Journal of Dermatology, 60, pp. 23 - 28, http://dx.doi.org/10.1111/ajd.12899

Temel AB; Murrell DF, 2019, 'Diagnostic Criteria and Phenotypes of Pemphigoid and the Association with Gliptins', JAMA Dermatology, 155, pp. 147 - 148, http://dx.doi.org/10.1001/jamadermatol.2018.4847

Harris AG; Saikal SL; Murrell DF, 2019, 'Epidermolysis Bullosa Patients' Perception of Surgical Wound and Scar Healing', Dermatologic Surgery, 45, pp. 280 - 289, http://dx.doi.org/10.1097/DSS.0000000000001673

Yang A; Xuan R; Murrell DF, 2019, 'A new indirect immunofluorescence BIOCHIP method for the serological diagnosis of bullous pemphigoid: A review of literature', Australasian Journal of Dermatology, 60, pp. e173 - e177, http://dx.doi.org/10.1111/ajd.13034

Has C; Amber KT; Murrell DF; Musette P; Ludwig RJ, 2019, 'Editorial: Skin blistering diseases', Frontiers in Medicine, 6, http://dx.doi.org/10.3389/fmed.2019.00060

Hébert V; Boulard C; Houivet E; Duvert Lehembre S; Borradori L; Della Torre R; Feliciani C; Fania L; Zambruno G; Camaioni DB; Didona B; Marinovic B; Schmidt E; Schumacher N; Hünefeld C; Schanz S; Kern JS; Hofmann S; Bouyeure AC; Picard-Dahan C; Prost-Squarcioni C; Caux F; Alexandre M; Ingen-Housz-Oro S; Bagot M; Tancrede-Bohin E; Bouaziz JD; Franck N; Vabres P; Labeille B; Richard MA; Delaporte E; Dupuy A; D'Incan M; Quereux G; Skowro F; Paul C; Livideanu CB; Beylot-Barry M; Doutre MS; Avenel-Audran M; Bedane C; Bernard P; Machet L; Maillard H; Jullien D; Debarbieux S; Sassolas B; Misery L; Abasq C; Dereure O; Lagoutte P; Ferranti V; Werth VP; Murrell DF; Hertl M; Benichou J; Joly P, 2019, 'Large International Validation of ABSIS and PDAI Pemphigus Severity Scores', Journal of Investigative Dermatology, 139, pp. 31 - 37, http://dx.doi.org/10.1016/j.jid.2018.04.042

Yeoh SC; Byth-Wilson K; Murrell DF; Schifter M; Lin MW; Fulcher DA, 2019, 'Pemphigus vulgaris disease activity: The role of antibodies to desmogleins and their isotype', Journal of Oral Pathology and Medicine, 48, pp. 619 - 625, http://dx.doi.org/10.1111/jop.12913

Saleh MA; Zaraa I; Doss N; Saleh NA; Murrell DF, 2019, 'Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases' patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires.', An Bras Dermatol, 94, pp. 399 - 404, http://dx.doi.org/10.1590/abd1806-4841.20197198

Guignant M; Murrell D; Schimdt E; Zillikens D; Prost C; Caux F; Joly P, 2019, 'Comment les experts internationaux traitent-ils les patients atteints de pemphigoïde bulleuse à travers le monde ?', Annales de Dermatologie et de Vénéréologie, 146, pp. A62 - A62, http://dx.doi.org/10.1016/j.annder.2019.09.039

Ferries L; Gilibert A; Alexandre M; Duvert-Lehembre S; Corbaux C; Hébert V; Prost-Squarcioni C; Caux F; Delaporte E; Litrowski N; Boulard C; Murrell D; Joly P, 2019, 'Corrélations entre les questionnaires de qualité de vie spécifiques aux maladies bulleuses auto-immunes ABQOL et TABQOL, et les scores de sévérité objectifs', Annales de Dermatologie et de Vénéréologie, 146, pp. A97 - A98, http://dx.doi.org/10.1016/j.annder.2019.09.100

Patsatsi A; Murrell DF, 2019, 'Multiple milia formation in blistering diseases', International Journal of Women's Dermatology, 5, pp. 275 - 275, http://dx.doi.org/10.1016/j.ijwd.2019.06.004

Makrgeorgou A; Leonardi-Bee J; Bath-Hextall FJ; Murrell DF; Tang MLK; Roberts A; Boyle RJ, 2018, 'Probiotics for treating eczema', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD006135.pub3

Wang EQ; Radjenovic M; Castrillón MA; Feng GHY; Murrell DF, 2018, 'The effect of autoimmune blistering diseases on work productivity', Journal of the European Academy of Dermatology and Venereology, 32, pp. 1959 - 1966, http://dx.doi.org/10.1111/jdv.15062

Back to profile page